Cabergolin-TEVA 0.5mg Tabletten (2 tabs)




Cabergolin-TEVA 0.5mg Tabletten (2 tabs)

Experience relief from the symptoms of hyperprolactinemia with Cabergolin-TEVA 0.5mg Tabletten. This powerful medication is designed to provide effective treatment and restore hormonal balance. With its unique formulation and proven results, Cabergolin-TEVA offers a reliable solution for those suffering from hyperprolactinemia.

Pharmacological Properties

  • Cabergolin-TEVA contains cabergoline, a potent dopamine receptor agonist.
  • It acts by inhibiting the secretion of prolactin, a hormone responsible for lactation and other related functions.
  • Its long half-life ensures sustained therapeutic effects.

Effects and Benefits

  • Normalizes prolactin levels, reducing symptoms such as irregular menstrual periods, infertility, and breast milk production in non-pregnant women.
  • Improves fertility by restoring ovulation in women with hyperprolactinemia-related infertility.
  • Reduces the size of prolactin-secreting tumors (prolactinomas) in the pituitary gland.
  • Relieves symptoms associated with prolactinomas, such as headaches, vision problems, and decreased libido.
  • Enhances overall quality of life by alleviating physical and emotional distress caused by hyperprolactinemia.

Correct Dosage and Overdose

It is important to follow the prescribed dosage instructions provided by your healthcare professional. Typically, the recommended starting dose of Cabergolin-TEVA is 0.25mg twice a week. The dosage may be gradually increased based on individual response and prolactin levels. However, the maximum recommended dose should not exceed 1mg per week.

In case of a missed dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one.

In the event of an overdose, seek immediate medical attention. Symptoms of overdose may include nausea, vomiting, hallucinations, and severe dizziness.

Indications and Contraindications

Cabergolin-TEVA is indicated for the treatment of hyperprolactinemia, including prolactin-secreting adenomas (prolactinomas) and related conditions. It is also used to restore fertility in women with hyperprolactinemia-related infertility.

However, Cabergolin-TEVA should not be used in the following cases:

  • Allergy to cabergoline or any of the tablet’s components.
  • Uncontrolled hypertension or severe cardiovascular disease.
  • History of fibrotic disorders, such as pulmonary fibrosis or cardiac valvulopathy.
  • Pregnancy or breastfeeding.

Side Effects

Like any medication, Cabergolin-TEVA may cause side effects in some individuals. Common side effects include:

  • Nausea and vomiting
  • Headache
  • Dizziness
  • Constipation
  • Abdominal pain
  • Fatigue

If these side effects persist or worsen, consult your healthcare professional. Serious side effects are rare but may include hallucinations, chest pain, and shortness of breath. Seek immediate medical attention if you experience any severe or unusual symptoms.

Value to the Customer

Cabergolin-TEVA offers immense value to customers by providing an effective and reliable solution for hyperprolactinemia. With its proven pharmacological properties, this medication helps restore hormonal balance, alleviating distressing symptoms and improving overall quality of life. By normalizing prolactin levels, Cabergolin-TEVA addresses the root cause of hyperprolactinemia, offering long-term relief and restoring fertility in women. With its convenient tablet form, it is easy to take and integrate into daily routines.

Choose Cabergolin-TEVA 0.5mg Tabletten and experience the benefits of a trusted and effective treatment for hyperprolactinemia. Regain control over your hormonal health and enjoy a better quality of life.

Additional information

Active ingredient




Amount of active ingredient


Pack of packs





There are no reviews yet.

Be the first to review “Cabergolin-TEVA 0.5mg Tabletten (2 tabs)”

Your email address will not be published. Required fields are marked *